EUVIMEDEUVIMED entdecken
ValidierungsstudieVergleichsstudie

Modification, validation and comparison of Naples prognostic score to determine in‐hospital mortality in ST ‐segment elevation myocardial infarction

Omer Genc iD, Abdullah Yildirim iD, Aslan Erdogan iD, Ersin Ibisoglu iD, Yeliz Guler iD, Gazi Capar iD, M Mert Goksu iD, Huseyin Akgun iD, Gamze Acar iD, G Cansu Ozdogan iD, Gunseli Uredi iD, Furkan Sen iD und 6 weitere

European Journal of Clinical Investigation · 2025

DOI: 10.1111/eci.14332 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Journal of Clinical Investigation, 2025. Verfasst von Omer Genc und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Basaksehir Cam & Sakura City Hospital, University of Health Sciences, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hospital Mortality, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, Biomarkers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The relationship between inflammatory status and poor outcomes in acute coronary syndromes is a significant area of current research. This study investigates the association between in‐hospital mortality and the modified Naples prognostic score (mNPS) as well as other inflammatory biomarkers in STEMI patients.

Methods

This single‐centre, cross‐sectional study included 2576 consecutive STEMI patients who underwent primary percutaneous coronary intervention between January 2022 and November 2023. Participants were randomly divided into derivation and validation cohorts in a 6:4 ratio. The following inflammatory indices were calculated: pan‐immune‐inflammation value (PIV), systemic immune‐inflammation‐index (SII), systemic inflammation‐response index (SIRI) and conventional NPS. The mNPS was derived by integrating hs‐CRP into the conventional NPS. The performance of these indices in determining in‐hospital mortality was assessed using regression, calibration, discrimination, reclassification and decision curve analyses.

Results

Inflammatory biomarkers, including PIV, SII, SIRI, NPS and mNPS, were significantly higher in patients who died during in‐hospital follow‐up compared to those discharged alive in both the derivation and validation cohorts. Multivariable logistic regression analyses were performed separately for the derivation and validation cohorts. In the derivation cohort, mNPS was associated with in‐hospital mortality (aOR = 1.490, p < .001). Similarly, in the validation cohort, mNPS was associated with in‐hospital mortality (aOR = 2.023, p < .001). mNPS demonstrated better discriminative and reclassification power than other inflammatory markers ( p < .05 for all). Additionally, regression models incorporating mNPS were well‐calibrated and showed net clinical benefit in both cohorts. Conclusion mNPS may be a stronger predictor of in‐hospital mortality in STEMI patients compared to the conventional scheme and other inflammatory indices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hospital MortalityST Elevation Myocardial InfarctionPercutaneous Coronary InterventionBiomarkersHumansMaleFemaleMiddle AgedAgedPrognosisCross-Sectional StudiesC-Reactive ProteinInflammationLogistic Models

Stichwörter der Autor:innen

Naples prognostic scoreST‐segment elevation myocardial infarctionmodified Naples prognostic scorepan‐immune‐inflammation valueprimary percutaneous coronary interventionsystemic immune‐inflammation indexsystemic inflammation response index

Substanzen

BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Department of Cardiology, Basaksehir Cam & Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
  • Department of Cardiology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey.
  • Department of Cardiology, Agri Training and Research Hospital, Agri, Turkey.
  • Department of Anesthesiology and Intensive Care, Prof. Dr. Cemil Tascioglu City Hospital, University of Health Sciences, Istanbul, Turkey.

ORCID-Profile: Omer Genc, Abdullah Yildirim, Aslan Erdogan, Ersin Ibisoglu, Yeliz Guler, Gazi Capar, M Mert Goksu, Huseyin Akgun, Gamze Acar, G Cansu Ozdogan, Gunseli Uredi, Furkan Sen, Ufuk S Halil, Fahri Er, Murside Genc, Eyup Ozkan, Ahmet Guler, Ibrahim H Kurt

Zitieren

APA

Genc, O., Yildirim, A., Erdogan, A., Ibisoglu, E., Guler, Y., Capar, G., Goksu, M. M., Akgun, H., Acar, G., Ozdogan, G. C., Uredi, G., Sen, F., Halil, U. S., Er, F., Genc, M., Ozkan, E., Guler, A., & Kurt, I. H. (2025). Modification, validation and comparison of Naples prognostic score to determine in‐hospital mortality in ST ‐segment elevation myocardial infarction. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14332

Vancouver

Genc O, Yildirim A, Erdogan A, Ibisoglu E, Guler Y, Capar G, et al. Modification, validation and comparison of Naples prognostic score to determine in‐hospital mortality in ST ‐segment elevation myocardial infarction. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.14332

BibTeX
@article{Genc2025,
  author = {Genc, Omer and Yildirim, Abdullah and Erdogan, Aslan and Ibisoglu, Ersin and Guler, Yeliz and Capar, Gazi and Goksu, M Mert and Akgun, Huseyin and Acar, Gamze and Ozdogan, G Cansu and Uredi, Gunseli and Sen, Furkan and Halil, Ufuk S and Er, Fahri and Genc, Murside and Ozkan, Eyup and Guler, Ahmet and Kurt, Ibrahim H},
  title = {Modification, validation and comparison of Naples prognostic score to determine in‐hospital mortality in ST ‐segment elevation myocardial infarction},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1111/eci.14332}
}
Kostenlos starten →